Fusidic Acid Actavis 2%

Land: Neuseeland

Sprache: Englisch

Quelle: Medsafe (Medicines Safety Authority)

Wirkstoff:

Fusidic acid 2%{relative}

Verfügbar ab:

Teva Pharma (New Zealand) Limited

INN (Internationale Bezeichnung):

Fusidic acid 2% w/w

Dosierung:

2% w/w

Darreichungsform:

Topical cream

Zusammensetzung:

Active: Fusidic acid 2%{relative} Excipient: Butylated hydroxyanisole Cetyl alcohol Glycerol Hydrochloric acid For purging - Low oxygen nitrogen Liquid paraffin Polysorbate 60 Potassium sorbate Purified water White soft paraffin

Verschreibungstyp:

Prescription

Hergestellt von:

Ercros S A

Anwendungsgebiete:

Indicated either alone or in combination with systemic therapy, in the treatment of primary and secondary skin infections caused by sensitive strains of Staphylococcus aureus, Streptococcus spp and Corynebacterium minutissimum. Primary skin infections that may be expected to respond to treatment with fusidic acid applied topically include: impetigo contagiosa, superficial folliculitis, sycosis barbae, paronychia and erythrasma; also such secondary skin infections as infected eczematoid dermatitis, infected contact dermatitis and infected cuts / abrasions.

Produktbesonderheiten:

Package - Contents - Shelf Life: Tube, aluminium, Collapsible tube lacquered internally by epoxy phenol based lacquer - 10 g - 24 months from date of manufacture stored at or below 25°C 6 months opened stored at or below 25°C - Tube, aluminium, Collapsible tube lacquered internally by epoxy phenol based lacquer - 15 g - 24 months from date of manufacture stored at or below 25°C 6 months opened stored at or below 25°C - Tube, aluminium, Collapsible tube lacquered internally by epoxy phenol based lacquer - 30 g - 24 months from date of manufacture stored at or below 25°C 6 months opened stored at or below 25°C

Berechtigungsdatum:

2015-04-22